HHealth Read More First clinical trial evaluates stem cell therapy for Huntington’s diseaseJuly 9, 2026 An update on the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for Huntington’s…
HHealth Read More Trial offers hope for babies with fetal kidney failureJuly 9, 2026 Women diagnosed early in pregnancy with a fetus lacking adequate kidney function to make the urine that serves…
HHealth Read More Trial supports glargine use in resource-limited Type 1 diabetes careJuly 7, 2026 A trial led by University of Pittsburgh researchers and published today in The Lancet Diabetes & Endocrinology adds nuance…
HHealth Read More Can ibuprofen improve drug-resistant tuberculosis treatment?July 3, 2026 Could a common over-the-counter anti-inflammatory drug become a new weapon against drug-resistant tuberculosis? Early findings suggest immune benefits,…
HHealth Read More Targeted therapy doubles progression-free survival in rare bile duct cancerJuly 2, 2026 Results of the ongoing eNRGy trial, a single-arm, multicenter, global phase 2 clinical trial evaluating zenocutuzumab in solid…
TTechnology Read More Ten weeks of cognitive rehabilitation reverses long Covid brain fogJuly 1, 2026 Ten weeks of cognitive rehabilitation can help people with long Covid symptoms such as brain fog achieve their…
SScience Read More Advanced brain interfacing technology for both touch and vision restorationJuly 1, 2026 Patients with untreatable conditions such as sight loss or loss of motor-function could be closer to a viable…
HHealth Read More Monoclonal antibody shows promise for treating acute respiratory distress syndromeJuly 1, 2026 Doctors have few options for patients who develop a life-threatening lung condition called acute respiratory distress syndrome, or…
TTechnology Read More Clinical trial evaluates generative AI support tool in primary careJune 26, 2026 A large real-world clinical trial has found that a generative AI-powered support tool used to support frontline clinicians…
MMedication Read More Lilly’s Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapyJune 26, 2026 The positive opinion is based on results from the Phase 3 BRUIN CLL-313 and BRUIN CLL-314 trials, previously…
MMedication Read More New Baldness Pill Boosts Hair Coverage by Up to 86% in Six MonthsJune 25, 2026 AI-generated image. A familiar hair-loss drug may be getting a major upgrade. A slow-release formulation of minoxidil, one…
HHealth Read More High-dose DHA reaches the brain but fails to protect memoryJune 25, 2026 High-dose DHA successfully reached the brains of older adults at increased risk of Alzheimer’s disease, but the two-year…